A

Agile Therapeutics Inc
F:0AL

Watchlist Manager
Agile Therapeutics Inc
F:0AL
Watchlist
Price: 1.11 EUR -1.77% Market Closed
Market Cap: 9.3m EUR

Wall Street
Price Targets

0AL Price Targets Summary
Agile Therapeutics Inc

There are no price targets for 0AL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Agile Therapeutics Inc Competitors:
Price Targets
AARTIDRUGS
Aarti Drugs Ltd
2% Downside
4569
Kyorin Holdings Inc
3% Downside
AGY
Allergy Therapeutics PLC
61% Upside
SECARE
Swedencare AB (publ)
18% Upside
KLBF
Kalbe Farma Tbk PT
9% Upside
INDOCO
Indoco Remedies Ltd
21% Downside

Revenue
Forecast

Revenue Estimate
Agile Therapeutics Inc

The compound annual growth rate of Agile Therapeutics Inc's revenue for the next 1 year is 81%.

N/A
Past Growth
81%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Agile Therapeutics Inc

Operating Income forecast
is not available for
Agile Therapeutics Inc

Net Income
Forecast

Net Income Estimate
Agile Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 0AL's stock price target?
Not Available

0AL doesn't have any price targets made by Wall Street professionals.

What is Agile Therapeutics Inc's Revenue forecast?
Projected CAGR
81%

The compound annual growth rate of Agile Therapeutics Inc's revenue for the next 1 year is 81%.

Back to Top